MedWatch – The FDA Safety Information and Adverse Event Reporting Program

ApothéCure and FDA notified all healthcare professionals of recent deaths associated with the use of compounded injectable Colchicine .5mg/ml, 4ml vials, lot number 20070122@26.  The company issued an immediate drug recall for all strengths, sizes and lots of compounded Injectable Colchicine sold within the last year.  Customers are asked to examine their stock for ApothéCure compounded Colchicine on hand and to discontinue use immediately and prepare the product to return to the company.

Read the complete 2007 MedWatch 2007 Safety summary, including a link to the Manufacturer’s Recall Notice and Return Fax Cover Sheet regarding this issue at: http://www.fda.gov/medwatch/safety/2007/safety07.htm#Colchicine